JP2022505989A5 - - Google Patents
Info
- Publication number
- JP2022505989A5 JP2022505989A5 JP2021523159A JP2021523159A JP2022505989A5 JP 2022505989 A5 JP2022505989 A5 JP 2022505989A5 JP 2021523159 A JP2021523159 A JP 2021523159A JP 2021523159 A JP2021523159 A JP 2021523159A JP 2022505989 A5 JP2022505989 A5 JP 2022505989A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- salt according
- salt
- inhibitors
- hiv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862751733P | 2018-10-29 | 2018-10-29 | |
| US62/751,733 | 2018-10-29 | ||
| PCT/IB2019/059238 WO2020089778A1 (en) | 2018-10-29 | 2019-10-28 | Quinazolinyl-indazole derivatives and their use as inhibitors of human immunodeficiency virus replication |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022505989A JP2022505989A (ja) | 2022-01-14 |
| JP2022505989A5 true JP2022505989A5 (https=) | 2022-11-04 |
| JP7526174B2 JP7526174B2 (ja) | 2024-07-31 |
Family
ID=68425185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523159A Active JP7526174B2 (ja) | 2018-10-29 | 2019-10-28 | キナゾリニル－インダゾール誘導体及びそのヒト免疫不全ウイルス複製の阻害剤としてのその使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20210403465A1 (https=) |
| EP (1) | EP3873607B1 (https=) |
| JP (1) | JP7526174B2 (https=) |
| ES (1) | ES2969030T3 (https=) |
| WO (1) | WO2020089778A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11541055B2 (en) | 2018-10-24 | 2023-01-03 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| JP2022506399A (ja) * | 2018-11-05 | 2022-01-17 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| EP4066839A4 (en) | 2019-11-28 | 2023-12-27 | Shionogi & Co., Ltd | PROPHYLACTIC AND THERAPEUTIC MEDICINAL PRODUCT FOR HIV INFECTIOUS DISEASES, CHARACTERIZED BY CONTAINING THE COMBINATION OF INTEGRAS INHIBITORS AND ANTI-HIV AGENTS |
| KR20220151655A (ko) * | 2020-03-06 | 2022-11-15 | 비브 헬스케어 유케이 (넘버5) 리미티드 | 인간 면역결핍 바이러스 복제의 억제제 |
| CN111548349A (zh) * | 2020-05-13 | 2020-08-18 | 厦门云凡医药科技有限公司 | 一种ret激酶抑制剂中间体及其制备方法 |
| US20250042926A1 (en) | 2023-05-31 | 2025-02-06 | Gilead Sciences, Inc. | Therapeutic compounds for hiv |
| CN121335877A (zh) | 2023-06-15 | 2026-01-13 | Viiv保健英国第五有限公司 | 用于制备化合物的方法和中间体 |
| TW202547514A (zh) | 2024-02-05 | 2025-12-16 | 英商Ｖｉｉｖ醫療保健英國(Ｎｏ 5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102464654B (zh) | 2010-11-12 | 2016-01-13 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| AU2012278976B2 (en) | 2011-07-06 | 2017-05-11 | Gilead Sciences, Inc. | Compounds for the treatment of HIV |
| CN102863512B (zh) | 2011-07-07 | 2016-04-20 | 上海泓博智源医药技术有限公司 | 抗病毒化合物 |
| US9220710B2 (en) | 2013-01-09 | 2015-12-29 | Gilead Sciences, Inc. | Therapeutic compounds |
| ES2642265T3 (es) | 2013-01-09 | 2017-11-16 | Gilead Sciences, Inc. | Compuestos terapéuticos para el tratamiento de infecciones virales |
| TW201443037A (zh) | 2013-01-09 | 2014-11-16 | Gilead Sciences Inc | 治療用化合物 |
| TWI694071B (zh) | 2013-03-01 | 2020-05-21 | 美商基利科學股份有限公司 | 治療反轉錄病毒科(Retroviridae)病毒感染之治療性化合物 |
| US10202353B2 (en) | 2014-02-28 | 2019-02-12 | Gilead Sciences, Inc. | Therapeutic compounds |
| WO2015130966A1 (en) | 2014-02-28 | 2015-09-03 | Gilead Sciences, Inc. | Antiviral agents |
| EP3186239B1 (en) | 2014-08-29 | 2018-10-10 | Gilead Sciences, Inc. | Antiretroviral agents |
| CN119462611A (zh) * | 2016-08-19 | 2025-02-18 | 吉利德科学公司 | 用于预防性或治疗性治疗hiv病毒感染的治疗性化合物 |
| TW201906834A (zh) * | 2017-05-02 | 2019-02-16 | 英商Viiv醫療保健英國(No.5)有限公司 | 人類免疫不全病毒複製之抑制劑 |
| JP7083398B2 (ja) | 2018-02-15 | 2022-06-10 | ギリアード サイエンシーズ， インコーポレイテッド | ピリジン誘導体およびｈｉｖ感染を処置するためのその使用 |
| EP3752496B1 (en) | 2018-02-16 | 2023-07-05 | Gilead Sciences, Inc. | Methods and intermediates for preparing a therapeutic compound useful in the treatment of retroviridae viral infection |
| EP3774775B8 (en) * | 2018-04-11 | 2023-11-15 | VIIV Healthcare UK (No.5) Limited | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication |
| EP3849982A1 (en) * | 2018-09-14 | 2021-07-21 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
| JP7433303B2 (ja) * | 2018-09-20 | 2024-02-19 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| ES2971987T3 (es) * | 2018-10-24 | 2024-06-10 | Viiv Healthcare Uk No 5 Ltd | Inhibidores de la replicación del virus de inmunodeficiencia humana |
| JP7500555B2 (ja) * | 2018-10-25 | 2024-06-17 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| JP2022506399A (ja) * | 2018-11-05 | 2022-01-17 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | ヒト免疫不全ウイルス複製の阻害剤 |
| US20210395248A1 (en) * | 2018-11-05 | 2021-12-23 | VIIV Healthcare UK (No.5) Limited | Inhibitors of human immunodeficiency virus replication |
-
2019
- 2019-10-28 EP EP19797382.9A patent/EP3873607B1/en active Active
- 2019-10-28 US US17/285,680 patent/US20210403465A1/en not_active Abandoned
- 2019-10-28 JP JP2021523159A patent/JP7526174B2/ja active Active
- 2019-10-28 WO PCT/IB2019/059238 patent/WO2020089778A1/en not_active Ceased
- 2019-10-28 ES ES19797382T patent/ES2969030T3/es active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022505989A5 (https=) | ||
| JP2022505597A5 (https=) | ||
| JP2022505841A5 (https=) | ||
| JP2022500425A5 (https=) | ||
| JP2022505637A5 (https=) | ||
| JP2022501370A5 (https=) | ||
| JP2003503385A5 (https=) | ||
| JP2017537126A5 (https=) | ||
| JP2020507589A5 (https=) | ||
| JP2024173998A5 (https=) | ||
| JP2020512337A5 (https=) | ||
| JP2006506425A5 (https=) | ||
| BRPI0715492A2 (pt) | uso de inibidores diretos de trombina | |
| JP2019522024A5 (https=) | ||
| JP2008534453A5 (https=) | ||
| JP2008508214A (ja) | 女性の性障害の治療用ピペラジン誘導体 | |
| JP2021530513A5 (https=) | ||
| RU2019141734A (ru) | Терапевтические соединения и композиции и способы их применения | |
| RU99101081A (ru) | Режим введения ингибиторов н+, к+-атфазы | |
| JP2022531251A5 (https=) | ||
| JP2019528279A5 (https=) | ||
| RU2009148507A (ru) | Производное тетрагидроизохинолин-1-она или его соль | |
| RU2003130644A (ru) | Производные ркарболина и их фармацевтическое применение против дипрессии и страха | |
| JP2022551691A5 (https=) | ||
| JP2025508656A5 (https=) |